Financials
- Market Capitalization 8.57 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3 449
売上高対価格比率
5.56
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 962 | CYTK Cytokinetics, Incorporated - Common Stock | 62.87 USD | -0.06% | -0.43% | -14.47% | +8.21% | 8.74 B USD | ||
| 963 | AXSM Axsome Therapeutics, Inc. - Common Stock | 166.56 USD | -1.06% | -6.41% | -24.95% | +27.93% | 8.72 B USD | ||
| 982 | TGTX TG Therapeutics, Inc. - Common Stock | 55.04 USD | -0.60% | +1.51% | +1.98% | +63.47% | 8.42 B USD | ||
| 1043 | SYRE Spyre Therapeutics, Inc. - Common Stock | 86.23 USD | +0.63% | -6.53% | -4.82% | +260.64% | 7.60 B USD |